Type 1 Diabetes clinical trials
Showing 151–200 of 210 active trials. Describe your situation to see which ones you may be eligible for.
- PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
- Food is Medicine in Pediatric Patients With Diabetes
- Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes
- App-Based Certified Diabetes Education Therapy (AB-CDE)
- CKM For Safe Use of SGLT2i in Type 1 Diabetes
- Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications
- Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans
- Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Pilot of Food Is Medicine Interventions to Reduce Cardiovascular Disease Risk in Children With Food Insecurity and Diabetes
- Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors
- GLP-1 RA for Stage 1 Type 1 Diabetes
- Finding Immune Nascent Type 1 Diabetes
- Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes
- Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes
- Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
- Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
- Screening For Social Determinants Of Health In Routine Diabetes Care
- Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
- Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
- Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring
- Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus
- Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
- Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D
- Technology Knowledge Optimization for Type 1 Diabetes in Schools
- Argus 2.0 Adoption Study
- Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy
- Personalized Comprehensive Diabetes Support for Children With Newly Diagnosed Type 1 Diabetes
- The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
- Multicenter Assessment of the Pancreas in Type 1 Diabetes
- Sleep Screening and Intervention for Adolescents With Type 1 Diabetes in a Clinical Diabetes Center
- Estimating Insulin Sensitivity in Pregnancies With Type 1 Diabetes
- BETA - Pilot Study
- The T1D Talks Pilot Study
- Type 1 Diabetes Autonomic and Vascular Function
- Impact of Integrated Pet Care on Glycemic Control and Diabetes Responsibility
- Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1D
- School Partnered Collaborative Care (SPACE) Intervention for Children With Type 1 Diabetes
- 4T Sustainability Program
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
- PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
- Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes
- Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
- FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
- Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
- Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
- Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
- AIDANET Pediatrics
- TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
- Dapagliflozin Plus Pioglitazone in T1DM
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.